Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry
Introduction The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the Spanish population. We carried out a study with the objectives: (i) To describe the incidence of TB in patients with psoriasis on systemic tr...
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2013-11, Vol.27 (11), p.1366-1374 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1374 |
|---|---|
| container_issue | 11 |
| container_start_page | 1366 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 27 |
| creator | Sánchez-Moya, A.I. García-Doval, I. Carretero, G. Sánchez-Carazo, J. Ferrandiz, C. Herrera Ceballos, E. Alsina, M. Ferrán, M. López-Estebaranz, J.-L. Gómez-García, F. De la Cueva Dobao, P. Carrascosa, J.-M. Vanaclocha, F. Belinchón, I. Peral, F. Dauden, E. |
| description | Introduction The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the Spanish population. We carried out a study with the objectives: (i) To describe the incidence of TB in patients with psoriasis on systemic treatment in the Spanish population; (ii) To determine the prevalence of LTBI in patients who are candidates for biological treatment; and (iii) To investigate the level of compliance with current recommendations for LTBI and TB screening.
Methods Data were obtained from BIOBADADERM (Spanish registry for systemic biological and non‐biological treatments in psoriasis). An analysis was performed of the exposed cohort to determine the prevalence of LTBI and to describe compliance with the screening guidelines.
Results A total of 1425 patients were registered in BIOBADADERM. They included 793 (56%) patients exposed to biological treatment and 632 (44%) treated with conventional systemic drug. Overall follow‐up was 3720 person‐years. Of the 793, 20.5% (163) were diagnosed with LTBI before starting biological treatment. The rate of active TB for the exposed cohort was 145 cases × 100 000 patient‐years (95% CI 54–389). No case of TB was found in the control group. Screening for LTBI was performed in 83% of the exposed sample.
Conclusion Patients with psoriasis who are exposed to biological treatment appear to be at greater risk for tuberculosis. In Spain, up to 20% of patients with psoriasis who are candidates for biological therapy have LTBI. There continues to be a significant percentage of errors in compliance with clinical guidelines. |
| doi_str_mv | 10.1111/jdv.12011 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1464501555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1464501555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3961-b37a61e3a5c605993054410ab606244acc2f28230fa9a9168a01167db49ed8af3</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEokvhwB9APsIhWzt2vDG3bbeUlm0r8VVu1sSZULfZJNjOlv3jnPGy3SK-JHyxJT_vO6OZN0meMjpm8exdVcsxyyhj95IRE7JIOS34_WREVSZTpXK1kzzy_orSiOTFw2Qn44yLTBaj5NscAraBhKFEZ4am89YT29Zogu1aAm1FID6X-DtBegg2Kj25seGS9L5zFuLXSwLEh6FakSgPlxhRYytsDZKu_tVkbb4meodLaLZI85eGKusRPP5ZdtFV6KIg9bhEhz_bWKPverDtmOwfn-9PZ9PZ4dtT4vCz9cGtHicPamg8Prm9d5MPrw7fH7xO5-dHxwfTeWq4kiwt-QQkQw65kTRXitNcCEahlFRmQoAxWZ0VGac1KFBMFhAnLCdVKRRWBdR8N3m-8e1d92VAH_TCeoNNAy12g9dxWyKnLM_z_0BF3BkrFI_oiw1qXOe9w1r3zi7ArTSjep0IHROhfyQiss9ubYdygdUduY1ABPY2wI1tcPVvJ30y-7i1TDeKOEr8eqcAd63lhE9yfXF2pOkbcTI_u_ikT_l3oIHUig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1443421893</pqid></control><display><type>article</type><title>Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sánchez-Moya, A.I. ; García-Doval, I. ; Carretero, G. ; Sánchez-Carazo, J. ; Ferrandiz, C. ; Herrera Ceballos, E. ; Alsina, M. ; Ferrán, M. ; López-Estebaranz, J.-L. ; Gómez-García, F. ; De la Cueva Dobao, P. ; Carrascosa, J.-M. ; Vanaclocha, F. ; Belinchón, I. ; Peral, F. ; Dauden, E.</creator><creatorcontrib>Sánchez-Moya, A.I. ; García-Doval, I. ; Carretero, G. ; Sánchez-Carazo, J. ; Ferrandiz, C. ; Herrera Ceballos, E. ; Alsina, M. ; Ferrán, M. ; López-Estebaranz, J.-L. ; Gómez-García, F. ; De la Cueva Dobao, P. ; Carrascosa, J.-M. ; Vanaclocha, F. ; Belinchón, I. ; Peral, F. ; Dauden, E. ; BIOBADADERM Study Group ; the BIOBADADERM Study Group</creatorcontrib><description>Introduction The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the Spanish population. We carried out a study with the objectives: (i) To describe the incidence of TB in patients with psoriasis on systemic treatment in the Spanish population; (ii) To determine the prevalence of LTBI in patients who are candidates for biological treatment; and (iii) To investigate the level of compliance with current recommendations for LTBI and TB screening.
Methods Data were obtained from BIOBADADERM (Spanish registry for systemic biological and non‐biological treatments in psoriasis). An analysis was performed of the exposed cohort to determine the prevalence of LTBI and to describe compliance with the screening guidelines.
Results A total of 1425 patients were registered in BIOBADADERM. They included 793 (56%) patients exposed to biological treatment and 632 (44%) treated with conventional systemic drug. Overall follow‐up was 3720 person‐years. Of the 793, 20.5% (163) were diagnosed with LTBI before starting biological treatment. The rate of active TB for the exposed cohort was 145 cases × 100 000 patient‐years (95% CI 54–389). No case of TB was found in the control group. Screening for LTBI was performed in 83% of the exposed sample.
Conclusion Patients with psoriasis who are exposed to biological treatment appear to be at greater risk for tuberculosis. In Spain, up to 20% of patients with psoriasis who are candidates for biological therapy have LTBI. There continues to be a significant percentage of errors in compliance with clinical guidelines.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.12011</identifier><identifier>PMID: 23134268</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Cohort Studies ; Data processing ; Female ; Guideline Adherence ; Humans ; Incidence ; Latent Tuberculosis - complications ; Latent Tuberculosis - epidemiology ; Male ; Middle Aged ; Mycobacterium ; Practice Guidelines as Topic ; Prevalence ; Psoriasis - complications ; Psoriasis - epidemiology ; Severity of Illness Index ; Spain - epidemiology ; Tuberculosis - complications ; Tuberculosis - epidemiology</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2013-11, Vol.27 (11), p.1366-1374</ispartof><rights>2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology</rights><rights>2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3961-b37a61e3a5c605993054410ab606244acc2f28230fa9a9168a01167db49ed8af3</citedby><cites>FETCH-LOGICAL-c3961-b37a61e3a5c605993054410ab606244acc2f28230fa9a9168a01167db49ed8af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.12011$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.12011$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23134268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Moya, A.I.</creatorcontrib><creatorcontrib>García-Doval, I.</creatorcontrib><creatorcontrib>Carretero, G.</creatorcontrib><creatorcontrib>Sánchez-Carazo, J.</creatorcontrib><creatorcontrib>Ferrandiz, C.</creatorcontrib><creatorcontrib>Herrera Ceballos, E.</creatorcontrib><creatorcontrib>Alsina, M.</creatorcontrib><creatorcontrib>Ferrán, M.</creatorcontrib><creatorcontrib>López-Estebaranz, J.-L.</creatorcontrib><creatorcontrib>Gómez-García, F.</creatorcontrib><creatorcontrib>De la Cueva Dobao, P.</creatorcontrib><creatorcontrib>Carrascosa, J.-M.</creatorcontrib><creatorcontrib>Vanaclocha, F.</creatorcontrib><creatorcontrib>Belinchón, I.</creatorcontrib><creatorcontrib>Peral, F.</creatorcontrib><creatorcontrib>Dauden, E.</creatorcontrib><creatorcontrib>BIOBADADERM Study Group</creatorcontrib><creatorcontrib>the BIOBADADERM Study Group</creatorcontrib><title>Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Introduction The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the Spanish population. We carried out a study with the objectives: (i) To describe the incidence of TB in patients with psoriasis on systemic treatment in the Spanish population; (ii) To determine the prevalence of LTBI in patients who are candidates for biological treatment; and (iii) To investigate the level of compliance with current recommendations for LTBI and TB screening.
Methods Data were obtained from BIOBADADERM (Spanish registry for systemic biological and non‐biological treatments in psoriasis). An analysis was performed of the exposed cohort to determine the prevalence of LTBI and to describe compliance with the screening guidelines.
Results A total of 1425 patients were registered in BIOBADADERM. They included 793 (56%) patients exposed to biological treatment and 632 (44%) treated with conventional systemic drug. Overall follow‐up was 3720 person‐years. Of the 793, 20.5% (163) were diagnosed with LTBI before starting biological treatment. The rate of active TB for the exposed cohort was 145 cases × 100 000 patient‐years (95% CI 54–389). No case of TB was found in the control group. Screening for LTBI was performed in 83% of the exposed sample.
Conclusion Patients with psoriasis who are exposed to biological treatment appear to be at greater risk for tuberculosis. In Spain, up to 20% of patients with psoriasis who are candidates for biological therapy have LTBI. There continues to be a significant percentage of errors in compliance with clinical guidelines.</description><subject>Adult</subject><subject>Cohort Studies</subject><subject>Data processing</subject><subject>Female</subject><subject>Guideline Adherence</subject><subject>Humans</subject><subject>Incidence</subject><subject>Latent Tuberculosis - complications</subject><subject>Latent Tuberculosis - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mycobacterium</subject><subject>Practice Guidelines as Topic</subject><subject>Prevalence</subject><subject>Psoriasis - complications</subject><subject>Psoriasis - epidemiology</subject><subject>Severity of Illness Index</subject><subject>Spain - epidemiology</subject><subject>Tuberculosis - complications</subject><subject>Tuberculosis - epidemiology</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEokvhwB9APsIhWzt2vDG3bbeUlm0r8VVu1sSZULfZJNjOlv3jnPGy3SK-JHyxJT_vO6OZN0meMjpm8exdVcsxyyhj95IRE7JIOS34_WREVSZTpXK1kzzy_orSiOTFw2Qn44yLTBaj5NscAraBhKFEZ4am89YT29Zogu1aAm1FID6X-DtBegg2Kj25seGS9L5zFuLXSwLEh6FakSgPlxhRYytsDZKu_tVkbb4meodLaLZI85eGKusRPP5ZdtFV6KIg9bhEhz_bWKPverDtmOwfn-9PZ9PZ4dtT4vCz9cGtHicPamg8Prm9d5MPrw7fH7xO5-dHxwfTeWq4kiwt-QQkQw65kTRXitNcCEahlFRmQoAxWZ0VGac1KFBMFhAnLCdVKRRWBdR8N3m-8e1d92VAH_TCeoNNAy12g9dxWyKnLM_z_0BF3BkrFI_oiw1qXOe9w1r3zi7ArTSjep0IHROhfyQiss9ubYdygdUduY1ABPY2wI1tcPVvJ30y-7i1TDeKOEr8eqcAd63lhE9yfXF2pOkbcTI_u_ikT_l3oIHUig</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Sánchez-Moya, A.I.</creator><creator>García-Doval, I.</creator><creator>Carretero, G.</creator><creator>Sánchez-Carazo, J.</creator><creator>Ferrandiz, C.</creator><creator>Herrera Ceballos, E.</creator><creator>Alsina, M.</creator><creator>Ferrán, M.</creator><creator>López-Estebaranz, J.-L.</creator><creator>Gómez-García, F.</creator><creator>De la Cueva Dobao, P.</creator><creator>Carrascosa, J.-M.</creator><creator>Vanaclocha, F.</creator><creator>Belinchón, I.</creator><creator>Peral, F.</creator><creator>Dauden, E.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>201311</creationdate><title>Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry</title><author>Sánchez-Moya, A.I. ; García-Doval, I. ; Carretero, G. ; Sánchez-Carazo, J. ; Ferrandiz, C. ; Herrera Ceballos, E. ; Alsina, M. ; Ferrán, M. ; López-Estebaranz, J.-L. ; Gómez-García, F. ; De la Cueva Dobao, P. ; Carrascosa, J.-M. ; Vanaclocha, F. ; Belinchón, I. ; Peral, F. ; Dauden, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3961-b37a61e3a5c605993054410ab606244acc2f28230fa9a9168a01167db49ed8af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Cohort Studies</topic><topic>Data processing</topic><topic>Female</topic><topic>Guideline Adherence</topic><topic>Humans</topic><topic>Incidence</topic><topic>Latent Tuberculosis - complications</topic><topic>Latent Tuberculosis - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mycobacterium</topic><topic>Practice Guidelines as Topic</topic><topic>Prevalence</topic><topic>Psoriasis - complications</topic><topic>Psoriasis - epidemiology</topic><topic>Severity of Illness Index</topic><topic>Spain - epidemiology</topic><topic>Tuberculosis - complications</topic><topic>Tuberculosis - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Moya, A.I.</creatorcontrib><creatorcontrib>García-Doval, I.</creatorcontrib><creatorcontrib>Carretero, G.</creatorcontrib><creatorcontrib>Sánchez-Carazo, J.</creatorcontrib><creatorcontrib>Ferrandiz, C.</creatorcontrib><creatorcontrib>Herrera Ceballos, E.</creatorcontrib><creatorcontrib>Alsina, M.</creatorcontrib><creatorcontrib>Ferrán, M.</creatorcontrib><creatorcontrib>López-Estebaranz, J.-L.</creatorcontrib><creatorcontrib>Gómez-García, F.</creatorcontrib><creatorcontrib>De la Cueva Dobao, P.</creatorcontrib><creatorcontrib>Carrascosa, J.-M.</creatorcontrib><creatorcontrib>Vanaclocha, F.</creatorcontrib><creatorcontrib>Belinchón, I.</creatorcontrib><creatorcontrib>Peral, F.</creatorcontrib><creatorcontrib>Dauden, E.</creatorcontrib><creatorcontrib>BIOBADADERM Study Group</creatorcontrib><creatorcontrib>the BIOBADADERM Study Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Moya, A.I.</au><au>García-Doval, I.</au><au>Carretero, G.</au><au>Sánchez-Carazo, J.</au><au>Ferrandiz, C.</au><au>Herrera Ceballos, E.</au><au>Alsina, M.</au><au>Ferrán, M.</au><au>López-Estebaranz, J.-L.</au><au>Gómez-García, F.</au><au>De la Cueva Dobao, P.</au><au>Carrascosa, J.-M.</au><au>Vanaclocha, F.</au><au>Belinchón, I.</au><au>Peral, F.</au><au>Dauden, E.</au><aucorp>BIOBADADERM Study Group</aucorp><aucorp>the BIOBADADERM Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2013-11</date><risdate>2013</risdate><volume>27</volume><issue>11</issue><spage>1366</spage><epage>1374</epage><pages>1366-1374</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Introduction The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the Spanish population. We carried out a study with the objectives: (i) To describe the incidence of TB in patients with psoriasis on systemic treatment in the Spanish population; (ii) To determine the prevalence of LTBI in patients who are candidates for biological treatment; and (iii) To investigate the level of compliance with current recommendations for LTBI and TB screening.
Methods Data were obtained from BIOBADADERM (Spanish registry for systemic biological and non‐biological treatments in psoriasis). An analysis was performed of the exposed cohort to determine the prevalence of LTBI and to describe compliance with the screening guidelines.
Results A total of 1425 patients were registered in BIOBADADERM. They included 793 (56%) patients exposed to biological treatment and 632 (44%) treated with conventional systemic drug. Overall follow‐up was 3720 person‐years. Of the 793, 20.5% (163) were diagnosed with LTBI before starting biological treatment. The rate of active TB for the exposed cohort was 145 cases × 100 000 patient‐years (95% CI 54–389). No case of TB was found in the control group. Screening for LTBI was performed in 83% of the exposed sample.
Conclusion Patients with psoriasis who are exposed to biological treatment appear to be at greater risk for tuberculosis. In Spain, up to 20% of patients with psoriasis who are candidates for biological therapy have LTBI. There continues to be a significant percentage of errors in compliance with clinical guidelines.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>23134268</pmid><doi>10.1111/jdv.12011</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2013-11, Vol.27 (11), p.1366-1374 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1464501555 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adult Cohort Studies Data processing Female Guideline Adherence Humans Incidence Latent Tuberculosis - complications Latent Tuberculosis - epidemiology Male Middle Aged Mycobacterium Practice Guidelines as Topic Prevalence Psoriasis - complications Psoriasis - epidemiology Severity of Illness Index Spain - epidemiology Tuberculosis - complications Tuberculosis - epidemiology |
| title | Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A39%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Latent%20tuberculosis%20infection%20and%20active%20tuberculosis%20in%20patients%20with%20psoriasis:%20a%20study%20on%20the%20incidence%20of%20tuberculosis%20and%20the%20prevalence%20of%20latent%20tuberculosis%20disease%20in%20patients%20with%20moderate-severe%20psoriasis%20in%20Spain.%20BIOBADADERM%20registry&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=S%C3%A1nchez-Moya,%20A.I.&rft.aucorp=BIOBADADERM%20Study%20Group&rft.date=2013-11&rft.volume=27&rft.issue=11&rft.spage=1366&rft.epage=1374&rft.pages=1366-1374&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.12011&rft_dat=%3Cproquest_cross%3E1464501555%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1443421893&rft_id=info:pmid/23134268&rfr_iscdi=true |